CONMED | CNMD - Loan Capital


CONMED reported $853.01M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
3M USD 10.91B 26M Mar/2026
Abbott USD 9.9B 1.7B Dec/2025
Accuray USD 127.32M 3.53M Sep/2025
AtriCure USD 61.86M 0 Dec/2025
Avanos Medical USD 90.3M 3.1M Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 11.01B 19M Dec/2025
CONMED USD 853.01M 28.1M Sep/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.53B 1.91B Mar/2026
Masimo USD 518M 41.1M Dec/2025
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Olympus JPY 159.64B 74.23B Dec/2025
Orthofix International USD 174.45M 17.23M Dec/2025
ResMed USD 403.92M 4.74M Dec/2025
Smith & Nephew USD 3.3B 22M Dec/2025
Steris USD 1.9B 1.1M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025